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Ανασκόπηση
  Cerebrospinal fluid analysis 
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    Η ανάλυση του εγκεφαλονωτιαίου υγρού
Πολυζοπούλου Ζ. Σ.
Διαγνωστικό Εργαστήριο, Τμήμα Κτηνιατρικής, Σχολή Επιστημών Υγείας, 
Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, 54627 Θεσσαλονίκη
ABSTRACT
The significance of cerebrospinal fluid (CSF) analysis has been compared to that of complete blood counts for systemic diseases. 
CSF changes generally follow specific patterns depending on the etiopathogenesis (inflammatory, metabolic, neoplastic) of neu-
rological diseases, thus indicating which further diagnostic modalities should be applied. CSF collection requires operator skills 
and knowledge of sampling indications and contraindications. Analysis includes physical examination (colour, clarity, viscosity), 
cytological and biochemical analysis, microbiological and immunologic testing. Despite its limitations, CSF analysis is a useful 
diagnostic tool, in particular when results are interpreted in combination with historical information, clinical examination and the 
findings of clinicopathological and diagnostic imaging testing.
Keywords: cerebrospinal fluid, diagnosis, neurological diseases, animals 
ΠΕΡΙΛΗΨΗ
Η ανάλυση του εγκεφαλονωτιαίου υγρού (ΕΝΥ) είναι η σημαντικότερη εργαστηριακή εξέταση στη διαγνωστική διερεύνηση 
των παθήσεων του νευρικού συστήματος των ζώων, που ανάλογα με την αιτιολογία τους προκαλούν συνήθως συγκεκριμένου 
τύπου παθολογικές μεταβολές στη σύστασή του. Η δειγματοληψία του ΕΝΥ γίνεται με ατλαντοϊνιακή ή οσφυϊκή παρακέντηση 
του υπαραχνοειδούς χώρου, με την προϋπόθεση ότι δεν υπάρχει οποιαδήποτε από τις γνωστές αντενδείξεις (αύξηση ενδοκρανια-
κής πίεσης, αδυναμία χορήγησης γενικής αναισθησίας, απειρία εξεταστή). Η ανάλυση περιλαμβάνει την εκτίμηση των φυσικών 
χαρακτηριστικών (χρώμα, διαφάνεια, ιξώδες), την κυτταρολογική (ποσοτική και ποιοτική), τη βιοχημική (μέτρηση ολικών πρω-
τεϊνών και γλυκόζης), τη μικροβιολογική και τις ανοσολογικές εξετάσεις. Η διαγνωστική αξία των ευρημάτων της ανάλυσης του 
ΕΝΥ ενισχύεται περαιτέρω αν συνδυαστεί με τα στοιχεία του ιστορικού, της κλινικής και της νευρολογικής εξέτασης και ιδιαί-
τερα με τα αποτελέσματα των ειδικών απεικονιστικών εξετάσεων.
Λέξεις ευρετηρίασης: εγκεφαλονωτιαίο υγρό, διάγνωση, νοσήματα νευρικού συστήματος ζώων
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INTRODUCTION
Cerebrospinal fluid (CSF) is a colorless, trans-parent fluid that surrounds the central nervous 
system (CNS) acting as a protective, nourishing and 
supporting agent (Chrisman, 1992). The clinical im-
portance of CSF analysis has been compared to that 
of complete blood counts regarding the diagnostic in-
vestigation of systemic abnormalities. CSF changes 
tend to follow specific patterns associated with the 
pathophysiology of neurological diseases (inflamma-
tory, metabolic, neoplastic) showing a satisfactory 
sensitivity in their detection but a low specificity, es-
pecially if a basic interpretation (total nucleated cell 
count and total protein estimation) is done (Vernau et 
al., 2008). Moreover, there are several neurological 
entities where no CSF abnormalities can be detected 
and this may be attributed to the location (proxim-
ity to the ventricular system and subarachnoid space) 
and severity of lesions (for example, meningeal ver-
sus intraparenchymal cerebral lesions) (Wamsley, 
2013). CSF abnormalities may be masked by pre-
vious treatments, especially corticosteroids (Jami-
son and Lumsden, 1988). Given the aforementioned 
limitations, it is obvious that CSF analysis is a useful 
diagnostic tool only when its results are interpreted 
in combination with historical information, clinical 
examination and the findings of clinicopathological 
and diagnostic imaging testing (Vernau et al., 2008).
PHYSIOLOGY AND COMPOSITION OF CSF
CSF is produced mainly by selective blood 
plasma ultrafiltration and active (energy utilizing) 
transport from the ependymal lining of the choroid 
plexi in the lateral, 3rd and 4th ventricles. To a lesser 
degree, CSF is also produced from the leptomenin-
geal and brain tissue capillaries (De Lahunta and 
Glass, 2009). CSF then follows a caudal flow into 
the central canal of the spinal cord and through the 
brain tissue to the subarachnoid space, where it is 
reabsorbed into the venous circulation via the arach-
noid villi (Wamsley, 2013).  
The rate of CSF production is constant and 
varies depending on the animal species and physi-
ologic conditions. Reported rates in the dog and cat 
are 0.047 and 0.017 ml/min, respectively and the 
entire volume of CSF is produced and absorbed 3 
to 5 times per day (Vernau et al., 2008; De Lahunta 
and Glass, 2009). The rate of CSF production is not 
influenced by the arterial blood pressure but from 
blood osmotic pressure and therefore the intrave-
nous administration of hypertonic solutions lowers 
CSF production (hence its clinical application in the 
treatment of cerebral edema) (De Lahunta and Glass, 
2009). 
The functions of CSF include physical support 
and protection of CNS tissue, removal of large pro-
tein molecules and cells (the “lymphatic” function of 
CSF), intracerebral transport of biologically active 
substances formed in the hypothalamus (among 
them thyrotropin, corticotropin, growth hormone 
and gonadotropin releasing hormones) and homeos-
tasis control of CNS microenvironment (Di Terlizzi 
and Platt, 2006; Vernau et al., 2008).
Regarding its chemical composition (Table 1), 
compared to the blood plasma CSF contains more 
sodium, chloride and magnesium but less calcium 
and potassium. Its glucose content is 80% of the cor-
responding plasma concentration while its total pro-
tein is much lower than plasma and does not normal-
ly exceed 30 mg/100ml (Fishman, 1992; Kjedlsberg 
and Knight, 1993). Under normal conditions, the 
entrance of drugs and many other chemical sub-
stances produced in the body is prevented by sev-
eral interfaces that isolate the brain from systemic 
circulation, such as the blood-brain, the blood-CSF 
and the CSF-brain barriers (De Lahunta and Glass, 
2009). Serum proteins with a molecular weight in 
excess of 160,000 daltons are prevented to enter the 
CSF, unless the blood-brain barrier (BBB) is com-
promised. Nearly all protein types in normal CSF 
are derived from serum, with the exception of pre-
albumin, transferrin, beta and gamma trace proteins, 
tau protein, glial fibrillary acidic protein and myelin 
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dermal squamous cells (Kjeldsberg and Knight, 
1986; Cook and DeNicola, 1988; Christopher, 1992).
COLLECTION OF CSF
Indications for collection and analysis of CSF 
include suspicion for diffuse or multifocal intrac-
ranial disease, polyneuropathy and myelopathy 
(Chrisman, 1992; Sharp and Wheeler, 2004). This 
procedure is done with the animal under general 
anesthesia and this should be accounted for upon 
decision making as some patients may be at a great-
er risk of its complications (Sharp and Wheeler, 
2004; Di Terlizzi and Platt, 2009). Except from 
the high risk of anesthetic complications further 
contraindications for CSF sampling include sus-
pected increased intracranial pressure (ICP), active 
intracranial or intraspinal hemorrhage (unless mye-
lography is to follow), suspicion of atlantoaxial 
subluxation (due to the danger associated with posi-
tioning) (Sharp and Wheeler, 2004). In these cases 
it is preferable to postpone CSF evaluation or select 
an advanced imaging modality (CT/MRI) in order 
to pursue diagnosis. It is recommended to collect 
CSF prior to certain diagnostic imaging techniques 
(myelography), as the injected contrast medium 
sometimes elicits a transient meningeal irritation 
(De Lahunta and Glass, 2009; Wamsley, 2013). 
basic protein which seem to be synthesized locally. 
Albumin, synthesized only in the liver, is the main 
CSF protein, whereas three major immunoglobulins 
(IgG, IgM and IgA) are also identified in normal ani-
mals (Fishman, 1992; Kjedlsberg and Knight, 1993). 
Several enzymes have been detected in the CSF of 
animals, their levels being however lower than the 
corresponding serum values. To date, none of these 
assays has proven to be of diagnostic significance in 
veterinary medicine (Fishman, 1992; Kjedlsberg and 
Knight, 1986).
Regarding its cellular composition, CSF is vir-
tually devoid of erythrocytes and its total nucle-
ated cell count (TNCC) is low (Table 1). Although 
controversies exist regarding the normal TNCC it 
is generally accepted that it should range from 0-2 
cells/μl (in dogs and cats), with 3 cells/μl being mar-
ginally and ≥4 cells/μl definitely abnormal, respec-
tively (Vernau et al., 2008). Normal CSF nucleated 
cells consist of small lymphocytes and monocytes. 
The latter are the dominant CSF type in dogs, cats 
and horses, while small lymphocytes predominate 
in cattle (Jamison and Lumsden, 1988; Rand et al., 
1990; Welles et al., 1992; Furr and Bender, 1994). 
Occasionally, other cell types may be found in nor-
mal CSF including leptomeningeal, ependymal and 
choroid plexus cells, chondrocytes or bone marrow 
cells (in samples obtained via lumbar puncture) and 
Table 1. Normal cerebrospinal fluid analysis findings
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CSF can be collected via subarachnoid space 
paracentesis at the cisterna magna (cerebelomedul-
lary cistern) or the lumbar spine (L5-L6 in the dog or 
L6-L7 in cats). The former is the preferred collection 
site, as it allows the sampling of larger CSF volumes 
and is easier to perform (Vernau et al., 2008; Di 
Terlizzi and Platt, 2009). The animal is placed in lat-
eral recumbency with the head and neck positioned 
near the edge of the table. The collection site clipped 
and surgically prepared. The neck of the animal is 
flexed at a 90° angle and the nose lifted to set the 
muzzle parallel to the table (Figure 1). Landmarks 
for needle insertion include the occipital protuber-
ance and lateral wings of the atlas (C1) which form 
a triangle in the center of which lies the optimal 
paracentesis site (Figure 1). The spinal needle is 
advanced slowly and the stylet removed periodically 
to check for CSF flow. In case the needle contacts 
bone it should be removed and landmarks reevalu-
ated. If CSF is grossly hemorrhagic, a few drops 
should be discarded to see whether it clears and then 
obtain a sample. If however blood appears in the nee-
dle hub the needle is discarded and the procedure has 
to be done from start (Chrisman, 1992).
CSF SAMPLE HANDLING
CSF is collected via free flow into a sterile plas-
tic vial or by aspirating each drop that appears in the 
needle hub into a sterile syringe. Direct aspiration 
from the spinal needle is contraindicated. If the sam-
ple is grossly hemorrhagic then an aliquot should 
be transferred into an EDTA tube to avoid clotting, 
however if microbiologic testing is to be done plain 
transport tubes should be used. EDTA tubes are 
required if the samples are to be sent for polymerase 
chain reaction (PCR) evaluation (Di Terlizzi and 
Platt, 2009).
One milliliter of CSF per 5 kg of bodyweight 
(or in general 0.75-2 ml in total) is more than suffi-
cient for several diagnostic tests (Carmichael, 1998). 
A small aliquot of the obtained sample must be 
saved separately in sterile plastic vials for microbio-
logical testing (culture and sensitivity) if an infec-
tious disorder is suspected. It has been anecdotally 
stated that cytological evaluation of CSF samples 
should be done within 30 minutes from collection, 
as subsequent cell degeneration associated with its 
low protein content (Cook and DeNicola, 1988; 
Oliver and Lorenz, 1993). More recent studies  on 
the effects of time, composition and addition of 
stabilizing agents have concluded that CSF samples 
have to be processed as soon as possible, however 
delayed (from 4 up to 8 hours) analysis may not 
alter clinical interpretation significantly (Fry et al., 
2006). Cell degeneration is evident first in the small 
mononuclear cell population, followed by the large 
mononuclear cells, neutrophils and finally eosi-
nophils (Fry et al., 2006).
To improve the preservation and quality of 
cytological evaluation it is advised that CSF sam-
ples should be divided after collection. One aliquot 
should be saved for cytology and preserved either 
by refrigeration at 4°C, or by the addition of stabi-
lizing agents such as 10% homologous serum from 
the patient, hetastarch solution (1:1 mixture) or 20% 
fetal bovine serum (Bienzle et al., 2000; Fry et al., 
Figure 1. 
CSF collection from the cerebellomedullary cistern (cisterna 
magna). The large black dot on the right side indicates the occipi-
tal protuberance, the dotted line on the left delineates the trans-
verse distance of the atlas wings and the X mark indicates the 
proposed centesis site.
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Total protein concentration
In health CSF total protein content is consid-
erably lower compared to plasma or serum, due to 
the functions of the intact blood-brain barrier that 
prevents large size molecules from entering the 
subarachnoid space (Di Terlizzi and Platt, 2006). 
The reference intervals for normal CSF total pro-
tein content vary among diagnostic laboratories 
and also depend on the assay methodology applied 
(Levine and Levine, 2012). Furthermore, total pro-
tein concentration increases rostrally to caudally 
along the neuraxis (neuraxis concentration gradi-
ent) with lumbar taps yielding higher values than 
cisternal (Vernau et al., 2008) (Table 1). Accurate 
CSF protein measurement is done using special 
analytical methods (Coomassie blue, pyrogallol red, 
immunoturbidimetric assays) and diagnostic labora-
tories. The use of refractometers and urine dipstick 
readings is discouraged as they may yield inaccurate 
results (Vernau et al., 2008). Furthermore, urine dip-
sticks detect primarily albumin and not globulins, 
which are known to increase in inflammatory CNS 
disorders.
Nearly all of the proteins present in CSF are 
derived from plasma and albumin is the major (80-
95%) protein type detected. Despite the low albu-
min content, CSF to serum albumin ratio (albumin 
quotient or index= CSF albumin ¸ serum albumin) is 
kept constant and therefore its calculation could be 
useful in assessing the integrity of the blood-brain 
barrier (Di Terlizzi and Platt, 2009). 
Other protein types that have been investigated 
for their diagnostic potential include myelin basic 
protein, associated with degenerative myelopathy 
(Oji et al., 2007), and C-reactive protein (CRP) 
which may help distinguishing bacterial and viral 
meningoencephalitis (Fishman, 1992).
Immunologic testing
The detection of antibodies against specific 
infectious agent is an additional diagnostic tool to be 
2006). The second aliquot should be saved for total 
protein determination and marked accordingly as 
both the addition of homologous or fetal bovine 




Normal CSF is transparent and colorless and 
therefore any change affecting these characteristics is 
considered an abnormality. Pink or red discoloration 
indicate the presence of blood, either through a trau-
matic tap or very recent (within the past hours) sub-
arachnoid hemorrhage. The latter is an uncommon 
cause of CSF red coloration because free erythro-
cytes start to degenerate within 1-4 hours in the sub-
arachnoid space and fluid collection rarely coincides 
with their presence. In this case, sample centrifuga-
tion results in the formation of a erythrocyte “pel-
let” at the bottom of the tube while the supernatant 
remains clear (Cook and DeNicola, 1988). The pres-
ence of pink or reddish, “thread-like” swirls during 
CSF flow into the sampling vial suggest iatrogenic 
blood contamination (Levine and Levine, 2012). 
Yellow and yellow-orange CSF discoloration 
(xanthochromia) is the result of hemoglobin deg-
radation within the subarachnoid space or second-
ary to an increase of total protein concentration, 
hyperbilirubinemia, CNS neoplasia and inflammation 
(Kjeldsberg and Knight, 1986; Cook and DeNicola, 
1988). In subarachnoid hemorrhage xanthochromia 
persists for 24 hours after the event and subsequently 
dissipates within the next 4-8 days, while eryth-
rophagocytosis may also be detected in microscop-
ic examination of the CSF sediment (Jamison and 
Lumsden, 1988; Levine and Levine, 2012).
Increased CSF turbidity is commonly attributed 
to marked (>500 cells/μL) pleocytosis, as mild to 
moderate increases in TNCC do not affect its clarity 
(Chrisman, 1992).
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tinely measured by automated cell counters. Instead, 
a manual cell enumeration is done using a haemo-
cytometer (Neubauer chamber), which is loaded on 
both sides with CSF and incubated for 5-10 minutes 
before cell counting. The TNCC is then calculated 
from the average of the two side counts using the 
equation [Number of cells x 10/9 = cells/ μl].
Increased TNCC (pleocytosis) may be scored as 
mild (less than 25 cells/ μl), moderate (26-100 cells/ 
μl) and marked (more than 100 cells/ μl) (Cook and 
DeNicola, 1988). The scoring of pleocytosis does 
depend on the severity of the inciting cause, as well 
as other factors (CSF collection site, lesion proximi-
ty to the subarachnoidal space etc). According to the 
predominating cell type, pleocytosis may be further 
classified as neutrophilic, eosinophilic, mononuclear 
or mixed (Freeman and Raskin, 2001).
Distinguishing erythrocytes from white blood 
cells requires practice, in particular when small lym-
phocytes are present. TNCC and CSF total protein 
content usually increase in parallel in most neuro-
logical disorders, however in some cases the former 
remain within normal limits while the latter increas-
es (albuminocytological dissociation). Increased 
protein concentration with a normal TNCC (albu-
minocytological dissociation) suggests disruption of 
the BBB with subsequent leakage of serum protein 
in CNS or intrathecal protein production. It has been 
associated with a variety of primary and secondary 
neurological disorders such as myelitis, space-occu-
pying lesions, degenerative vascular and compressive 
myelopathies (Chrisman, 1992; Vernau et al., 2008).
The microscopic examination of cytological 
preparations is mandatory in all CSF samples, even 
if the TNCC is within normal limits because differ-
ential cell count and / or morphological abnormali-
ties may still occur (Di Terlizzi and Platt, 2009).
Differential cell count
CSF cytological slide preparation is optimally 
done using cytocentrifuge equipment, capable of 
applying low speed centrifugation in order to con-
used along with conventional CSF analysis and neu-
roimaging techniques. Gamma globulins present in 
CSF include IgG (the dominant fraction), IgM and 
IgA. Results should be interpreted bearing in mind 
the prevalence and exposure frequency of particular 
diseases and the antibody type (IgM, IgG) involved. 
IgM is mainly associated with recent infection while 
IgG with more chronic disease course (Levine and 
Levine, 2012). IgA increases both intrathecally and 
systemically in dogs with steroid responsive menin-
gitis-arteritis (Tipold, 1995). CSF immunoglobulin 
content may be attributed to intrathecal synthesis 
(as in neurological disorders) or non-specific diffu-
sion through the damaged BBB (Tipold et al., 1994). 
The IgG ratio of the serum to CSF immunoglobulin 
content (IgG index) and the antibody index may be 
useful for specific cases where there is a strong sus-
picion of infectious disease. The IgG index is calcu-
lated as follows: IgG in CSF : IgG in serum, divided 
by the albumin quotient of the same patient (Vernau 
et al. 2008).
In some cases assessment of CSF antibody tit-
ers for specific infectious diseases may be more 
useful than the relevant in serum, as they represent 
intrathecal production secondary to a local stimulus. 
On the other hand, disruption of the BBB, a com-
mon feature of several CNS inflammatory diseases, 
may result in CSF “contamination” and artefac-
tual antibody titer elevation (Vernau et al., 2008; Di 
Terlizzi and Platt, 2009).
Polymerase chain reaction (PCR) testing may 
contribute to the diagnosis of infectious diseases, 
in particular when the isolation of organisms is not 
possible. Available PCR assays include canine dis-
temper, feline leukemia and feline immunodeficien-
cy virus, Toxoplasma gondii, Neospora caninum, 
Ehrlichia canis, Borrelia burgdorferi, Bartonella 
spp. infections. 
Total nucleated cell count (TNCC)
Normal CSF cell count is very low (less than 
5 nucleated cells/μl) and therefore it cannot be rou-
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centrate cells on a small area of the slide while pre-
serving their integrity. Alternatively, a sedimentation 
chamber prepared from a syringe barrel and mounted 
on a glass slide (Figure 2) may be used for in-house 
cytological preparations (Chrisman, 1992). CSF 
is loaded in the chamber and allowed to settle for 
30 minutes to facilitate cell sedimentation onto the 
slide (Table 2). In the case of delayed analysis due 
to sample shipment to a diagnostic laboratory, cell 
degeneration may be prevented by refrigeration and 
adding either homologous serum or hetastarch to a 
sample aliquot. This aliquot must be labeled properly 
as the addition of serum will increase total protein 
content, whereas hetastarch will dilute the sample 
(Bienzle et al., 2000; Fry et al., 2006). Regardless of 
the methodology used, slides are then air dried and 
stained with a Romanowsky stain (Wright Giemsa, 
Diff Quick). Special staining techniques may be 
applied if specific pathogens are suspected (Cook 
and DeNicola, 1988).  
Normal CSF cells are typically small lym-
phocytes (dog) or monocytes (cat), however eryth-
rocytes may be also present due to iatrogenic sample 
contamination (Cook and DeNicola, 1988). The 
latter may be indicated at microscopic examination 
of CSF sediment smears by the presence of plate-
lets and the absence of phagocytosed erythrocytes 
(Wamsley, 2013). 
Neutrophilic pleocytosis, usually accom-
panied by increased protein content, is associated 
with inflammatory diseases (infectious, immune-
mediated) and is an indication for microbiologi-
cal evaluation (culture and sensitivity testing) of 
CSF (Cook and DeNicola, 1988; Chrisman, 1992). 
Infectious meningoencephalitis may also be accom-
panied by systemic signs (depression, anorexia, 
pyrexia), along with leukocyte toxic morphologic 
changes which are more characteristic in bacte-
rial infections. Pronounced neutrophilic pleocytosis 
is a common feature in canine steroid responsive 
meningitis-arteritis (Wamsley, 2013). Other causes of 
neutrophilic pleocytosis include CNS neoplasia, tran-
sient post-myelography meningeal (contrast media) 
irritation, cerebrocortical ischemia and necrosis fol-
ΠολΥΖοΠοΥλοΥ Ζ. Σ.                      221
Modified from Wamsley, 2013
Table 2. Methodology for the manual cerebrospinal fluid (CSF) sedimentation chamber assembly (Figure 2)
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parasitic (aberrant parasitic migration) encephalo-
myelitis (Chrisman, 1992; Windsor et al., 2009).
Mononuclear cell pleocytosis is characterized 
by the abundant presence of small lymphocytes or 
monocytoid (macrophage) cells. Lymphocytic ple-
ocytosis is considered to be the hallmark of viral 
encephalitides (distemper, rabies), but may be present 
in non-infectious inflammatory CNS conditions such 
as granulomatous meningoencephalitis, necrotizing 
meningoencephalitis, or even cerebrospinal lym-
phoma (Christopher et al., 1988; Higgins et al., 2008).
lowing severe cluster seizures or status epilepticus 
(Dickinson et al., 2006).
Eosinophilic pleocytosis is always associ-
ated with CNS pathology because normal CSF is 
devoid of eosinophils. Eosinophilic meningitis, 
meningoencephalitis/-myelitis are the neurologi-
cal disorders most commonly accompanied by CSF 
eosinophilic pleocytosis (Smith-Maxie et al., 1989; 
Windsor et al., 2009). Similar cytomorphological 
changes have been observed in protozoal (toxoplas-
mosis, neosporosis), fungal (cryptococcosis) and 
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Table 3. Common cerebrospinal fluid abnormalities in selected neurological diseases
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2013). Less commonly, various types of sample con-
taminants, usually originating from the path of the 
spinal needle, may also be detected. These may be 
keratinized, meningeal or ependymal cells, hemat-
opoietic bone marrow cells or even free myelin 
fragments, which may indicate demyelination (Di 
Terlizzi and Platt, 2009).
CONCLUDING REMARKS
Despite the evolution of advanced diagnostic 
modalities for the investigation of CNS disorders, 
CSF analysis still remains a vital and essential part 
in their diagnostic approach. Although an etiolog-
ic diagnosis is rarely established solely by CSF 
examination, the interpretation of its physical and 
chemical analysis findings and cytology patterns, 
along with diagnostic imaging assessment facilitates 
the establishment of differential diagnoses for the 
majority of clinical cases.
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Mixed pleocytosis, manifested as a cell popula-
tion consisting of lymphocytes, monocytes/ mac-
rophages, neutrophils, plasma cells or eosinophils, 
may be recorded in several types of encephalopa-
thies. It is typically observed in granulomatous 
meningoencephalitis (Di Terlizzi and Platt, 2009). 
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